BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Validation that mass spectrometry can act as a diagnostic screen for patient samples from NHS test centres (i.e. validating P1 to a clinical standard); and validation of workflow to certain specifications (i.e. turnaround time).
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Viapath Analytics LLP | OC392043 | £102,042 | - |
Government spending data: This supplier has received £67,301,809 in 591 payments (over £25k) from Guy's and St Thomas' NHS FT, NHS England, East Sussex Healthcare NHS Trust, Maidstone and Tunbridge Wells NHS Trust, Epsom and St Helier University Hospitals NHS Trust and 2 more public bodies (2015-05-31 to 2026-02-20). View full payment history →